COOPER COS INC/THE (COO) Stock News
NASDAQ:COO - Nasdaq - US2166485019 - Common Stock - Currency: USD
COO Latest News, Press Relases and Analysis
CooperCompanies Appoints Barbara Carbone to Board of Directors
SAN RAMON, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today that its...
CooperCompanies Appoints Barbara Carbone to Board of Directors
CooperCompanies Announces Release Date for Second Quarter 2025
SAN RAMON, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report...
CooperCompanies Announces Release Date for Second Quarter 2025
The Wyatt Foundation and The Conceive Fertility Foundation Announce Launch of 2025 IVF Grant Program
/PRNewswire/ -- The Wyatt Foundation and The Conceive Fertility Foundation announce today the launch of their 2025 IVF grant program, which will award $15,000...
Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks
Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.
CooperCompanies (COO): Buy, Sell, or Hold Post Q4 Earnings?
CooperCompanies’s stock price has taken a beating over the past six months, shedding 24.6% of its value and falling to $80.68 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
Mentions: TDG
Q4 Earnings Roundup: CooperCompanies (NASDAQ:COO) And The Rest Of The Medical Devices & Supplies - Diversified Segment
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including CooperCompanies (NASDAQ:COO) and its peers.
Wall Street Rockets As February Inflation Cools More Than Expected
Stocks surged Wednesday morning, with major indices poised to snap a two-day losing streak, as cooler-than-expected inflation reinforced expectations for Federal Reserve rate cuts in 2025.
Why CooperCompanies (COO) Stock Is Trading Lower Today
Shares of medical device company CooperCompanies (NASDAQ:COO) fell 8.1% in the pre-market session after the company reported weak fourth quarter results: revenue missed, which is never a good sign. EPS was in line while the company reiterated full-year sales guidance. Markets typically reward companies that beat and raise guidance. Overall, the results could have been better.
CooperCompanies (NASDAQ:COO) Misses Q4 Revenue Estimates, Stock Drops 11%
Medical device company CooperCompanies (NASDAQ:COO) fell short of the market’s revenue expectations in Q4 CY2024 as sales rose 3.6% year on year to $964.7 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $4.12 billion at the midpoint. Its non-GAAP profit of $0.92 per share was in line with analysts’ consensus estimates.
CooperCompanies Announces First Quarter 2025 Results
SAN RAMON, Calif., March 06, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial...
CooperCompanies Announces First Quarter 2025 Results
CooperCompanies Announces Release Date for First Quarter 2025
SAN RAMON, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO) today announced it will report first quarter 2025 financial results on...